WebMD Health (WBMD) Reports In-Line Q1 EPS, Affirms FY Guidance, Q2 Revenue Misses
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Leerink Partners Likes WebMD Health (WBMD), Reiterates OP
May 7, 2015 7:52 AM EDTLeerink Partners reiterates an Outperform rating on WebMD Health Corp. (NASDAQ: WBMD) with a price target set at $54. WebMD reported revenue of $143.3m and YoY growth of 7%. Management reaffirmed guidance for 2015, projecting a growth rate of 8%.
Leerink analyst Steven Wardel commented, "EPS... More
